EFX:NYSEEquifax, Inc. Analysis

Equifax (EFX) is trading just above its 20‑day SMA at roughly $152, yet remains below the 200‑day SMA, indicating a longer‑term bearish bias. The MACD line sits under the signal line and the histogram is negative, while the RSI at the mid‑30s points to oversold conditions that could spark a short‑term bounce. Fundamentally, the company appears undervalued – its forward PE of around 15 is well under the industry average of 31, and the DCF‑derived fair value of roughly $160 suggests a ~5% upside. Revenue is growing at double‑digit rates (≈14%), margins are solid (gross >56%, operating >17%), and free cash flow exceeds $1 bn, supporting the 1.5% dividend with a comfortable payout ratio under 40%. Volatility is elevated (≈40% 30‑day) and beta is modest, reflecting a stock that can swing sharply but is less correlated than the broader market. The upcoming conference presentations and recent analyst coverage reinforce confidence in the earnings outlook, while the stock’s proximity to a key support level around $150 adds a technical catalyst for upside if it holds.